Parminder Raina, scientific director of the McMaster Institute for Research on Aging, explains a new nationwide study that will investigate the spread and impact of COVID-19 on older adults.
A $4-million investment from Canada's COVID-19 Immunity Task Force will launch a national study to investigate the burden of SARS-CoV-2 infection among aging Canadians, a population that has been shown to be at greatest risk for severe outcomes from COVID-19 disease.
A new collaborative research project, conducted with more than 10 institutions across the country, will examine the experiences of older adults during the coronavirus pandemic.